Print page Close print preview
Logo Going International
New search | Conferencedetail
 

4th Annual Chronic Kidney Disease Drug Development Summit (CKD)

Evvnt Promotion / evvnt
Archive
-
01.03.2022 - 03.03.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 08:00 - 17:00
 
Conference themes
As SGLT2 inhibitors redefine standard of care, opportunities to establish efficacy with surrogate endpoints take a step forward, and molecular phenotyping of disease etiology enables reclassification of patients to clinically actionable subtypes; drug development for chronic kidney disease has never been more exciting.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Agnes Benardeau Senior Director, Head of Cardio-Renal Biology, Novo Nordisk, Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alan Yu, Professor and Kidney Institute Director, University of Kansas Medical Center and more.
 

Enquiries and Registration:

https://go.evvnt.com/915880-2?pid=4832
Mr. Jessica Durston
 
Categories
General Medicine
Languages
English
Congress fees
USD 2099.0 - USD 4996.0
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom